Related Experiment Videos
Progressive multifocal leukoencephalopathy: analysis of lesion development with diffusion-weighted MRI
I Mader1, U Herrlinger, U Klose
1Department of Neuroradiology, University Hospital Tübingen, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany.
Neuroradiology
|August 28, 2003
Summary
Progressive multifocal leukoencephalopathy (PML) is diagnosed using JC virus DNA tests. Diffusion-weighted imaging (DWI) on MRI may help assess PML disease activity and correlate with clinical progression.
Area of Science:
- Neurology
- Radiology
- Infectious Diseases
Background:
- Progressive multifocal leukoencephalopathy (PML) is a demyelinating disease affecting immunocompromised individuals.
- JC virus (JCV) replication in oligodendrocytes causes PML, typically diagnosed via JCV DNA detection.
- Assessing PML disease activity and progression is crucial for patient management.
Observation:
- Diffusion-weighted imaging (DWI) was utilized in two patients diagnosed with PML.
- DWI was the sole MRI sequence capable of identifying active disease progression in these patients.
- The extent of abnormal diffusion on DWI correlated with the rate of clinical worsening.
Findings:
- Diffusion-weighted imaging (DWI) shows promise in visualizing active PML lesions.
- Abnormal diffusion on DWI appears to be a quantifiable marker of disease progression.
- MRI, specifically DWI, may offer a non-invasive method to monitor PML activity.
Implications:
- DWI could become a valuable tool for assessing PML disease activity and guiding treatment.
- This technique may improve the monitoring of therapeutic responses in PML patients.
- Further research is warranted to validate DWI's role in managing PML.